CLARUS THERAPEUTICS HOLDINGS, INC. Increase (Decrease) in Deferred Revenue
CLARUS THERAPEUTICS HOLDINGS, INC. reported Increase (Decrease) in Deferred Revenue of $1.40 million for the 6-month period ending 2022-06-30, per its 10-Q filed 2022-08-19.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDeferredRevenue · last filed 2022-08-19
- CLARUS THERAPEUTICS HOLDINGS, INC. increase (decrease) in deferred revenue for the quarter ending 2022-06-30 was $999.00K.
- CLARUS THERAPEUTICS HOLDINGS, INC. increase (decrease) in deferred revenue for the quarter ending 2022-03-31 was $396.00K.
- CLARUS THERAPEUTICS HOLDINGS, INC. increase (decrease) in deferred revenue for the quarter ending 2021-12-31 was $758.00K, a 37.07% increase year-over-year.
- CLARUS THERAPEUTICS HOLDINGS, INC. increase (decrease) in deferred revenue for the quarter ending 2021-09-30 was -$220.00K.
- CLARUS THERAPEUTICS HOLDINGS, INC. increase (decrease) in deferred revenue for fiscal 2021 was $413.00K, a 64.76% decline from fiscal 2020.
- CLARUS THERAPEUTICS HOLDINGS, INC. increase (decrease) in deferred revenue for fiscal 2020 was $1.17M.
| Period end | Increase (Decrease) in Deferred Revenue 3 month | Increase (Decrease) in Deferred Revenue 6 month | Increase (Decrease) in Deferred Revenue 9 month | Increase (Decrease) in Deferred Revenue 12 month |
|---|---|---|---|---|
| 2022-06-30 | $999.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-19 | $1.40M 10-Q · filed 2022-08-19 | $2.15M derived: sum of 3 quarters · filed 2022-08-19 | $1.93M derived: sum of 4 quarters · filed 2022-08-19 |
| 2022-03-31 | $396.00K 10-Q · filed 2022-05-16 | $1.15M derived: sum of 2 quarters · filed 2022-05-16 | $934.00K derived: sum of 3 quarters · filed 2022-05-16 | $887.00K derived: sum of 4 quarters · filed 2022-08-19 |
| 2021-12-31 | $758.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | $538.00K derived: sum of 2 quarters · filed 2022-03-31 | $491.00K derived: sum of 3 quarters · filed 2022-08-19 | $413.00K 10-K · filed 2022-03-31 |
| 2021-09-30 | -$220.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-19 | -$267.00K derived: sum of 2 quarters · filed 2022-08-19 | -$345.00K 10-Q · filed 2021-11-19 | $208.00K derived: sum of 4 quarters · filed 2022-08-19 |
| 2021-06-30 | -$47.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-19 | -$125.00K 10-Q · filed 2022-08-19 | $428.00K derived: sum of 3 quarters · filed 2022-08-19 | |
| 2021-03-31 | -$78.00K 10-Q · filed 2022-05-16 | $475.00K derived: sum of 2 quarters · filed 2022-05-16 | ||
| 2020-12-31 | $553.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | $1.17M 10-K · filed 2022-03-31 | ||
| 2020-09-30 | $619.00K 10-Q · filed 2021-11-19 |